跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 8,217 条关于
“Outsourcing Facilities Association”
全部
8,217
临床试验
3,820
药物
21
机构
137
资讯
4,239
去年
FDA to Reconsider Ban on Compounded Versions of Lilly's Weight Loss Drug
去年
FDA Faces Legal Challenge Over Tirzepatide Shortage List Removal, Agrees to Reevaluation
去年
FDA to Reassess Tirzepatide Shortage Status Amidst Compounding Dispute
去年
FDA Removes Ozempic and Wegovy from Shortage List, Sparking Legal Challenge from Compounding Groups
去年
2024 GLP-1 Breakthroughs: Clinical Advances and Regulatory Developments Transform Treatment Landscape
去年
Eli Lilly Moves to Join Lawsuit Over GLP-1 Compounding as FDA Deadline Approaches
去年
Eli Lilly Seeks to Join Lawsuit on Compounded Drugs
去年
Viatris Wins Patent Battle Against Novo Nordisk Over Generic Wegovy
8个月前
Arizona Pharmacy Sues Eli Lilly and Novo Nordisk Over Alleged GLP-1 Market Suppression
去年
FDA Declares IV Fluid Shortage Following Hurricane Impact on Baxter Facilities
第 1 页，共 424 页
上一页
下一页
